...
首页> 外文期刊>American Journal of Case Reports >Acute Unilateral Vision Loss Due to Optic Neuropathy in a Patient with Systemic Lupus Erythematosus
【24h】

Acute Unilateral Vision Loss Due to Optic Neuropathy in a Patient with Systemic Lupus Erythematosus

机译:系统性红斑狼疮患者视神经病变引起的急性单侧视力丧失

获取原文
           

摘要

Patient: Female, 44 Final Diagnosis: Optic neuritis Symptoms: Unilateral vision loss Medication: — Clinical Procedure: Fundoscopic examination Specialty: Ophthalmology Objective: Rare disease Background: Systemic lupus erythematosus (SLE) causes sight-threatening, ophthalmologic problems that are frequently challenging to manage. Optic neuropathy is a rare ophthalmological complication of SLE that can progress to total bilateral vision loss if not identified and treated rapidly. We describe a patient with SLE who presented with an acute, painless unilateral optic neuropathy who subsequently experienced partial recovery of vision when treated with high-dose intravenous corticosteroids. Case Report: A 44-year-old female with known SLE presented with 4 days of painless, complete, and gradual vision loss in the right eye. Initial ophthalmologic examination revealed no light perception, afferent pupil defect, 4+ optic disc swelling, and 1+ venous tortuosity of the right eye. No hemorrhage or exudates were noted. Diagnostic workup revealed a lupus flare with elevated inflammatory markers including elevated anti-nuclear antibody, anti-ds-DNA antibody, anti-Sm antibody, and anti-phospholipid IgG antibody. The diagnosis of optic neuropathy was clinically established, and the patient was treated with high-dose intravenous corticosteroids. Her vision improved, and she was transitioned to oral corticosteroids with eventual significant improvement in her vision. Conclusions: Optic neuropathy is a rare and devastating ophthalmologic complication of SLE. The diagnosis can be made by linking key clinical findings on ophthalmologic examination with positive serological studies. If treated rapidly with immunosuppressive therapy, the vision loss can be reversed, and permanent blindness avoided. Although this rare complication is generally bilateral in nature, clinician must also be aware of unilateral disease and treat patients accordingly.
机译:患者:女,44岁最终诊断:视神经炎症状:单侧视力下降药物治疗:—临床程序:眼底镜检查专科:眼科目的:罕见疾病背景:系统性红斑狼疮(SLE)会引起视力威胁,眼科问题通常是挑战性的管理。视神经病变是SLE的一种罕见的眼科并发症,如果不及时发现和治疗,可能会发展成双侧视力丧失。我们描述了患有急性,无痛性单侧视神经病变的SLE患者,随后在接受大剂量静脉注射糖皮质激素治疗后出现视力的部分恢复。病例报告:一名已知SLE的44岁女性,右眼出现4天无痛,完全和逐渐的视力丧失。最初的眼科检查未发现光感,瞳孔传入缺陷,右眼视盘红肿4+和静脉曲折1+。没有发现出血或渗出物。诊断检查显示狼疮耀斑的炎症标志物升高,包括升高的抗核抗体,抗ds-DNA抗体,抗Sm抗体和抗磷脂IgG抗体。视神经病变的诊断已在临床上确立,并对该患者进行了大剂量静脉内糖皮质激素治疗。她的视力得到了改善,并且她过渡到口服皮质类固醇激素,最终使视力有了显着改善。结论:视神经病变是一种罕见的破坏性SLE眼科并发症。可以通过将眼科检查的关键临床发现与阳性血清学研究联系起来进行诊断。如果用免疫抑制疗法迅速治疗,视力丧失可以逆转,并避免永久性失明。尽管这种罕见的并发症通常是双侧的,但临床医生还必须意识到单侧疾病并相应地治疗患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号